By: Kerry Dooley Young From: medscape.com Radioactive iodine (RAI) treatment for hyperthyroidism was associated with an increased incidence of breast cancer but not with an overall increase in cancer incidence or mortality, a new study found. Researchers analyzed data from the University of Michigan’s de-identified database, examining cancer diagnoses among patients treated for hyperthyroidism between January 1, 2006, and December …
Alternative breast cancer treatment tied to about four times higher mortality, nationwide analysis finds
By: Sanjukta Mondal From: medicalxpress.com The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social media. This growing trend has become an increasing concern for oncology practitioners and patients, as it can affect treatment decisions and trust in evidence-based care. The worry isn’t unfounded, as a recent study involving patients with …
Medicaid expansion improves mortality in women with breast cancer – AuntMinnie
By: Amerigo Allegretto From: auntminnie.com Expanding Medicaid under the Affordable Care Act (ACA) is tied to lower overall mortality among women with breast cancer, according to research published January 27 in JAMA Network Open. However, these benefits were uneven among women of various racial and ethnic and socioeconomic backgrounds, wrote a team led by Oluwasegun Akinyemi, MD, PhD, from Howard …
ACS reports milestone increases in cancer survival
By: Amerigo Allegretto From: auntminnie.com Cancer mortality rates continue to decline, with five-year survival rates reaching milestones, according to the American Cancer Society’s (ACS) annual cancer statistics report released on January 13. The ACS reported that about seven in 10 people who were diagnosed with cancer are reaching the five-year survival milestone, up from less than half of people in …
Patient-Attributable Delays in Breast Cancer Care Linked to Increased Risk for 2-Year Mortality
Source This study was led by Desirée Martín-García, Hospital Universitario Costa del Sol, Marbella, Spain. I From: medscape.com TOPLINE: Patient-attributable delays exceeding 90 days in breast cancer care were associated with a more than threefold higher risk for 2-year mortality. Living alone emerged as the only independent predictor of prolonged patient-attributable delay (PPAD), increasing the risk for delay by 88.2%. …
Statins could reduce breast cancer mortality by a fifth
By: Dr. Liji Thomas, MD From: news-medical.net New analysis of nearly 700,000 breast cancer cases reveals that statins may significantly improve patient outcomes, challenging earlier beliefs about their limited role in cancer care. A study published in Nature’s British Journal of Cancer investigated the role of statins in breast cancer mortality and recurrence. Introduction Breast cancer is the most common …
Breast cancer mortality in women ages 20–49 significantly dropped between 2010 and 2020
By: American Association for Cancer Research From: medicalxpress.com From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) registry presented at the American Association for Cancer Research (AACR) Annual …
Study links frailty to five-year mortality rate among older women with breast cancer
By: Hebrew SeniorLife Institute for Aging Research From: medicalxpress.com A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, muscle weakness, physical inactivity, and weight loss, to five-year survival rates in older women with breast cancer. These findings suggest that managing frailty during chemotherapy could improve outcomes. Published in JAMA Network …
Central Nervous System Disease Drives Mortality in HER2+ Metastatic Breast Cancer Despite Longer Survival
By: Alexandra Gerlach From: .pharmacytimes.com Key Takeaways HER2+ MBC patients with CNS disease have longer overall survival than those with extracranial metastasis. CNS metastases in HER2+ breast cancer remain difficult to treat, requiring local therapies like radiotherapy. CNS progression is a major mortality cause in HER2+ MBC, highlighting the need for CNS-penetrant therapies. Clinical trials should include CNS disease patients …
Exploring the potential of statins in reducing breast cancer mortality
By: D Moosavi From: fredhutch.org Statins work like a vigilant janitor: they block an enzyme in the liver that produces cholesterol, much like a janitor might simply turn off a leaky faucet to prevent a room from flooding. Statins are firmly established in cardiovascular medicine for preventing heart attacks and strokes because they reduce cholesterol. Now, what is even more …